Skip to main content

Table 3 Estimated HbA1c and between-group differences for intervention and control groups

From: Update on the General Practice Optimising Structured Monitoring to Improve Clinical Outcomes in Type 2 Diabetes (GP-OSMOTIC) trial: statistical analysis plan for a multi-centre randomised controlled trial

  Estimated mean HbA1c (95% CI) Difference in estimated mean HbA1c and general HbA1c target of 7% Unadjusted Adjusted*
  Intervention group (n=) Control group (n=) Intervention group (n=) Control group (n=) Intervention vs. Control between-group differences (95% CI) P Value Intervention vs. Control between-group differences (95% CI) P Value
Baseline         
6 months         
12 months         
  1. *Adjusted for age, IRSD and history of severe hypoglycaemia